Original language | English (US) |
---|---|
Pages (from-to) | E174-E199 |
Journal | Stroke |
Volume | 49 |
Issue number | 5 |
DOIs | |
State | Published - 2018 |
Keywords
- Alleles
- Cognition
- Gait
- Quality of life
- White matter
ASJC Scopus subject areas
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
- Advanced and Specialized Nursing
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Stroke, Vol. 49, No. 5, 2018, p. E174-E199.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Advances in stroke 2017
AU - Bernhardt, Julie
AU - Zorowitz, Richard D.
AU - Becker, Kyra J.
AU - Keller, Emanuela
AU - Saposnik, Gustavo
AU - Strbian, Daniel
AU - Dichgans, Martin
AU - Woo, Daniel
AU - Reeves, Mathew
AU - Thrift, Amanda
AU - Kidwell, Chelsea S.
AU - Olivot, Jean Marc
AU - Goyal, Mayank
AU - Pierot, Laurent
AU - Bennett, Derrick A.
AU - Howard, George
AU - Ford, Gary A.
AU - Goldstein, Larry B.
AU - Planas, Anna M.
AU - Yenari, Midori A.
AU - Greenberg, Steven M.
AU - Pantoni, Leonardo
AU - Amin-Hanjani, Sepideh
AU - Tymianski, Michael
N1 - Funding Information: Dr Thrift receives funding from the National Health & Medical Research Council of Australia (GNT1042600). G. Howard receives funding from the National Institutes of Health (NIH). Dr Yenari receives funding from the Department of Veterans Affairs Merit Grant. Funding Information: Dr Bernhardt served as an Advisor on the DART Neuroscience trial (Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors) that was discontinued, attended the 2017 investigator meeting in Sydney, Australia, and established and cochaired the Stroke Recovery and Rehabilitation Roundtable. Dr Olivot received speaker fees from Bristol Myers Squibb and Pfizer, and serves as a consultant for Servier, Medtronic, and Astra Zeneca. Dr Pierot serves as a consultant for Balt, Microvention, and Penumbra. Dr Goyal serves as a consultant for Microvention, Stryker, and Medtronic Neurovascular, and as coprincipal investigator for ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) and SWIFT PRIME (Solitaire With the Intention For Thrombectomy as Primary Endovascular Treatment) trials. Medtronic provided a grant to University of Calgary toward the HERMES (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) collaboration. Stryker provided a research grant to the University toward the UNMASK EVT study (Decision Making Under Uncertainty in the Management of Acute Stroke With Endovascular Thrombectomy: Applying Principles From Neuroeconomics). G.A. Ford reports speaking fees from Medtronic. Dr Amin-Hanjani reports research support from Edge Therapeutics for the NEWTON trial (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage) and from the National Institutes of Health (no compensation). The other authors report no conflicts.
PY - 2018
Y1 - 2018
KW - Alleles
KW - Cognition
KW - Gait
KW - Quality of life
KW - White matter
UR - http://www.scopus.com/inward/record.url?scp=85056364394&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056364394&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.118.021380
DO - 10.1161/STROKEAHA.118.021380
M3 - Article
C2 - 29669874
AN - SCOPUS:85056364394
SN - 0039-2499
VL - 49
SP - E174-E199
JO - Stroke
JF - Stroke
IS - 5
ER -